Review: taking Verapamil hydrochloride and Magnesium sulfate together


Summary

Drug interactions are reported among people who take Verapamil hydrochloride and Magnesium sulfate together. This review analyzes the effectiveness and drug interactions between Verapamil hydrochloride and Magnesium sulfate. It is created by eHealthMe based on reports of 177 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Verapamil Hydrochloride

Verapamil hydrochloride has active ingredients of verapamil hydrochloride. It is often used in high blood pressure. (latest outcomes from Verapamil hydrochloride 3,401 users)

Magnesium Sulfate

Magnesium sulfate has active ingredients of magnesium sulfate. It is often used in constipation. (latest outcomes from Magnesium sulfate 8,544 users)

On Sep, 19, 2016

177 people who take Verapamil Hydrochloride, Magnesium Sulfate are studied.


Number of reports submitted per year:

Verapamil hydrochloride and Magnesium sulfate drug interactions.

Drug effectiveness over time:

Verapamil Hydrochloride:
  • < 1 month: 0.0% - (0 of 0 people)
  • 1 - 6 months: 100.0% - (1 of 1 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 100.0% - (1 of 1 people)
  • 2 - 5 years: 0.0% - (0 of 0 people)
  • 5 - 10 years: 100.0% - (2 of 2 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Magnesium Sulfate:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 0.0% - (0 of 0 people)
  • 6 - 12 months: 100.0% - (1 of 1 people)
  • 1 - 2 years: 0.0% - (0 of 0 people)
  • 2 - 5 years: 50.0% - (1 of 2 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 0.0% - (0 of 0 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Verapamil Hydrochloride:
  • female: 100.0% - (4 of 4 people)
  • male: 50.0% - (1 of 2 people)
Magnesium Sulfate:
  • female: 66.0% - (2 of 3 people)
  • male: 50.0% - (1 of 2 people)

Drug effectiveness by age:

Verapamil Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 100.0% - (1 of 1 people)
  • 60+: 75.0% - (3 of 4 people)
Magnesium Sulfate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 0.0% - (0 of 0 people)
  • 30-39: 0.0% - (0 of 0 people)
  • 40-49: 100.0% - (1 of 1 people)
  • 50-59: 0.0% - (0 of 0 people)
  • 60+: 50.0% - (2 of 4 people)

Most common drug interactions over time *:

< 1 month:
  • renal failure
  • anxiety
  • emotional distress
  • injury
  • pain
  • renal impairment
  • depression
  • fear
  • renal injury
  • stress
1 - 6 months:
  • adams-stokes syndrome
  • atrial fibrillation
  • atrioventricular block
  • fall
  • procedural pain
  • tendon disorder
  • therapeutic response decreased
  • haemorrhagic anaemia
  • renal haematoma
6 - 12 months:
  • weight gain - unintentional
  • depressed level of consciousness
1 - 2 years:
  • acne
  • angioedema
  • insomnia
  • migraine
  • sinusitis noninfective
2 - 5 years:
  • angioedema
not specified:
  • acute respiratory distress syndrome
  • haemorrhage intracranial
  • toxic epidermal necrolysis
  • hypoglycaemia
  • renal failure
  • anxiety
  • emotional distress
  • pain
  • injury
  • bacterial infection

Most common drug interactions by gender *:

female:
  • acute respiratory distress syndrome
  • haemorrhage intracranial
  • toxic epidermal necrolysis
  • hypoglycaemia
  • pain
  • anxiety
  • bacterial infection
  • renal failure
  • emotional distress
  • injury
male:
  • renal failure
  • anxiety
  • emotional distress
  • injury
  • multi-organ failure
  • pain
  • fear
  • renal impairment
  • renal injury
  • stress

Most common drug interactions by age *:

20-29:
  • hyperlactacidaemia
  • abdominal pain
  • abdominal rigidity
  • asthma
  • blindness
  • blood pressure increased
  • encephalopathy
  • grand mal convulsion
  • headache
  • pre-eclampsia
30-39:
  • dyspnoea
  • abdominal pain upper
  • acne
  • anaemia
  • blood albumin decreased
  • blood alkaline phosphatase increased
  • blood bilirubin increased
  • blood creatinine abnormal
  • blood creatinine decreased
  • blood pressure increased
40-49:
  • anhedonia
  • anxiety
  • emotional distress
  • epidermal necrolysis
  • fear
  • injury
  • pain
  • pruritus
  • renal failure
  • renal impairment
50-59:
  • anxiety
  • arthralgia
  • asthma
  • atelectasis
  • cardiac failure congestive
  • depression
  • emotional distress
  • fall
  • influenza
  • nervousness
60+:
  • acute respiratory distress syndrome
  • renal failure
  • anxiety
  • haemorrhage intracranial
  • hypoglycaemia
  • toxic epidermal necrolysis
  • emotional distress
  • injury
  • pain
  • bacterial infection

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Verapamil hydrochloride and Magnesium sulfate?

Can you answer these questions?

More questions for: Verapamil hydrochloride, Magnesium sulfate

You may be interested in these reviews

More reviews for: Verapamil hydrochloride, Magnesium sulfate

On eHealthMe, Verapamil hydrochloride (verapamil hydrochloride) is often used to treat high blood pressure. Magnesium sulfate (magnesium sulfate) is often used to treat constipation. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.